Clinical trial
Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or…
NCT00006250 · Lymphoma Trials Office, Other · Unknown status
Key facts
| NCT number | NCT00006250 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma |
| Official title | Randomized Trial of MCD Versus FMD in Untreated Advanced Follicular Lymphoma |
| Lead sponsor | Lymphoma Trials Office, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | chlorambucil, dexamethasone, fludarabine phosphate, mitoxantrone hydrochloride |
| Enrollment | 500 |
| Start date | May 1, 2000 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: